adenosine has been researched along with Intraocular Pressure in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (30.77) | 18.2507 |
| 2000's | 15 (38.46) | 29.6817 |
| 2010's | 10 (25.64) | 24.3611 |
| 2020's | 2 (5.13) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CC; Fu, HI; Hsu, JH; Lee, LY; Tung, KC | 1 |
| Aires, ID; Ambrósio, AF; Boia, R; Ferreira-Silva, J; Santiago, AR | 1 |
| Ahmed, F; Albers, DS; Baumgartner, RA; Li, G; Navarro, ID; Stamer, WD; Torrejon, KY; Unser, AM | 1 |
| Bar-Yehuda, S; Cohen, S; Fishman, P | 1 |
| Nagaoka, T; Nakabayashi, S; Tani, T; Yoshida, A; Yoshioka, T | 1 |
| Agarwal, P; Agarwal, R | 1 |
| Civan, MM; Do, CW; Karl, MO; Leung, CT; Li, A; Macknight, AD; McLaughlin, CW; Stone, RA; Wang, Z; Zellhuber-McMillan, S | 1 |
| Avila, MY; Besada, P; Civan, MM; Do, CW; Gao, ZG; Jacobson, KA; Jeong, LS; Joshi, B; Peterson-Yantorno, K; Stone, RA; Wang, Z | 1 |
| Avni, I; Bakshi, E; Barequet, IS; Bristol, DR; Chetrit, N; Cohn, I; Farbstein, M; Fishman, P; Fishman, S; Garzozi, HJ; Harpaz, Z; Jacobson, KA; Kerns, WD; Litvin, G; Sartani, G; Segev, F; Silverman, MH; Tomkins, O; Varssano, D; Yehuda, SB; Zadok, D | 1 |
| Civan, MM; Leung, CT; Li, A; Mitchell, CH; Peterson-Yantorno, K; Stamer, WD | 1 |
| Dorner, GT; Garhofer, G; Kolodjaschna, J; Resch, H; Schmetterer, L; Schmidl, D; Weigert, G; Wolzt, M | 1 |
| Epstein, DL; Gonzalez, P; Li, G; Luna, C; Spasojevic, I; Wu, J | 1 |
| Huang, WC; Luo, X; Yang, Z; Zhong, Y | 1 |
| Avila, MY; Civan, MM; Stone, RA | 2 |
| Crosson, CE; Daines, BS; Kent, AR; McAleer, MS | 1 |
| Ehrlich, P; Fuchsjäger-Mayrl, G; Luksch, A; Polska, E; Schmetterer, L | 1 |
| Endo, K; Hosokawa, T; Kogi, K; Konno, T; Nagai, A; Nakahata, N; Ohnuma, SY; Uchibori, T; Uemoto, K | 1 |
| Konno, T | 1 |
| Kogi, K; Konno, T; Murakami, A; Nagai, A; Nakahata, N; Uchibori, T | 1 |
| Kogi, K; Konno, T; Nagai, A; Nakahata, N; Uchibori, T | 2 |
| Avila, MY; Civan, MM; Coca-Prados, M; Jacobson, KA; Peterson-Yantorno, K; Stone, RA; Yang, H | 1 |
| Kogi, K; Konno, T; Nagai, A; Nakahata, N; Sato, A; Uchibori, T | 1 |
| Avila, MY; Civan, MM; Do, CW; Jacobson, KA; Stone, RA; Wang, Z | 1 |
| Crosson, CE | 2 |
| Crosson, CE; Gray, T | 2 |
| Sugrue, MF | 1 |
| Crosson, CE; Gabelt, BT; Kaufman, PL; Tian, B | 1 |
| Caicedo, M; Cepelík, J; Dedina, M; Hynie, S | 1 |
| Crosson, CE; Petrovich, M | 1 |
| Crosson, CE; Niazi, Z | 1 |
| Hennes, HJ; Jantzen, JP; Rochels, R; Wallenfang, T | 1 |
| Araie, M; Kiuchi, Y; Mishima, HK | 1 |
| Kiuchi, Y; Mishima, HK; Yamazaki, M; Yasumoto, T; Yokoyama, T | 1 |
| Fukami, S; Iijima, Y; Kaneko, M; Kiuchi, Y; Mishima, H; Yamazaki, M; Yasumoto, T; Yokoyama, T | 1 |
| Kiuchi, Y | 1 |
5 review(s) available for adenosine and Intraocular Pressure
| Article | Year |
|---|---|
Targeting the A3 adenosine receptor for glaucoma treatment (review).
Topics: Adenosine; Adenosine A3 Receptor Agonists; Anti-Inflammatory Agents; Apoptosis; Dry Eye Syndromes; Glaucoma; Humans; Intraocular Pressure; Receptor, Adenosine A3; Retinal Ganglion Cells | 2013 |
Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways.
Topics: Adenosine; Aqueous Humor; Ciliary Body; Drug Design; Gene Expression Regulation; Glaucoma; GTP-Binding Proteins; Humans; Intracellular Signaling Peptides and Proteins; Intraocular Pressure; Models, Molecular; Molecular Targeted Therapy; Protein Conformation; Protein Kinases; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Trabecular Meshwork | 2014 |
Adenosine, adenosine receptors and glaucoma: an updated overview.
Topics: Adenosine; Animals; Aqueous Humor; Glaucoma; Humans; Intraocular Pressure; Receptors, Purinergic P1 | 2013 |
[Role of adenosine in intraocular pressure].
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Drug Design; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Phenethylamines; Rabbits; Receptors, Adenosine A2 | 2004 |
New approaches to antiglaucoma therapy.
Topics: Adenosine; Animals; Antihypertensive Agents; Cannabinoids; Drug Design; Endothelins; Glaucoma; Guanylate Cyclase; Humans; Intraocular Pressure; Neuroprotective Agents | 1997 |
3 trial(s) available for adenosine and Intraocular Pressure
| Article | Year |
|---|---|
Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Administration, Oral; Cornea; Double-Blind Method; Dry Eye Syndromes; Electrocardiography; Female; Fluorophotometry; Humans; Intraocular Pressure; Male; Middle Aged; Tears; Treatment Outcome | 2010 |
Role of adenosine in the control of choroidal blood flow during changes in ocular perfusion pressure.
Topics: Adenosine; Adult; Choroid; Cross-Over Studies; Homeostasis; Humans; Injections, Intravenous; Intraocular Pressure; Male; Placebos; Regional Blood Flow; Suction; Vascular Resistance; Vasodilator Agents; Young Adult | 2011 |
Effects of adenosine on intraocular pressure, optic nerve head blood flow, and choroidal blood flow in healthy humans.
Topics: Adenosine; Adult; Blood Flow Velocity; Choroid; Cross-Over Studies; Double-Blind Method; Humans; Interferometry; Intraocular Pressure; Laser-Doppler Flowmetry; Lasers; Male; Optic Disk; Regional Blood Flow; Vasodilation; Vasodilator Agents | 2003 |
31 other study(ies) available for adenosine and Intraocular Pressure
| Article | Year |
|---|---|
Lowering the Intraocular Pressure in Rats and Rabbits by
Topics: Adenosine; Animals; Apoptosis; Cordyceps; Disease Models, Animal; Glaucoma; Intraocular Pressure; Male; Mycelium; Rabbits; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells | 2022 |
Activation of Adenosine A
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Cell Death; Cell Movement; Cell Proliferation; Glaucoma; Humans; Intraocular Pressure; Microglia; Optic Nerve; Optic Nerve Injuries; Phagocytosis; Rats; Receptor, Adenosine A3; Retinal Degeneration; Retinal Ganglion Cells | 2020 |
Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice.
Topics: Adenosine; Administration, Ophthalmic; Animals; Antihypertensive Agents; Aqueous Humor; Biomimetics; Blotting, Western; Cell Line; Collagen Type IV; Fibronectins; Humans; Immunohistochemistry; Intraocular Pressure; Luminescent Measurements; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Nitrates; Purines; Receptor, Adenosine A1; Tissue Scaffolds; Tonometry, Ocular; Trabecular Meshwork | 2018 |
Autoregulation of retinal blood flow in response to decreased ocular perfusion pressure in cats: comparison of the effects of increased intraocular pressure and systemic hypotension.
Topics: Adenosine; Animals; Cats; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Excitatory Amino Acid Agonists; Female; Homeostasis; Hypotension; Intraocular Pressure; Intravitreal Injections; Laser-Doppler Flowmetry; Male; N-Methylaspartate; Nitric Oxide; Ocular Hypertension; Regional Blood Flow; Retina; Vasodilator Agents | 2014 |
Electron probe X-ray microanalysis of intact pathway for human aqueous humor outflow.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Aqueous Humor; Cell Size; Chlorides; Electron Probe Microanalysis; Enzyme Inhibitors; Feasibility Studies; Humans; Hypotonic Solutions; Intraocular Pressure; Norbornanes; Osmotic Pressure; Ouabain; Phenethylamines; Phosphorus; Potassium; Receptor, Adenosine A1; Receptors, Adenosine A2; Sodium; Sodium-Potassium-Exchanging ATPase; Trabecular Meshwork | 2008 |
Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species.
Topics: Adenosine; Adenosine A3 Receptor Antagonists; Animals; Antihypertensive Agents; Cattle; Cell Size; Ciliary Body; Female; Intraocular Pressure; Male; Mice; Ocular Hypertension; Pigment Epithelium of Eye; Tonometry, Ocular | 2010 |
Mechanisms of ATP release by human trabecular meshwork cells, the enabling step in purinergic regulation of aqueous humor outflow.
Topics: Adenosine; Adenosine Triphosphate; Aqueous Humor; Blotting, Western; Connexins; Glaucoma; HEK293 Cells; Humans; Intraocular Pressure; Luminescent Measurements; Microscopy, Confocal; Nerve Tissue Proteins; Real-Time Polymerase Chain Reaction; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; Trabecular Meshwork | 2012 |
Endogenous production of extracellular adenosine by trabecular meshwork cells: potential role in outflow regulation.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Aqueous Humor; Cells, Cultured; Cyclic AMP; Extracellular Space; Gene Expression Regulation, Enzymologic; Glaucoma; Intraocular Pressure; Membrane Microdomains; Mice; Mice, Inbred Strains; Stress, Mechanical; Swine; Trabecular Meshwork | 2012 |
Knockout of A3 adenosine receptors reduces mouse intraocular pressure.
Topics: Adenosine; Administration, Topical; Animals; Dihydropyridines; Intraocular Pressure; Mice; Mice, Inbred C57BL; Mice, Knockout; Ophthalmic Solutions; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1 | 2002 |
Intraocular adenosine levels in normal and ocular-hypertensive patients.
Topics: Adenosine; Aqueous Humor; Case-Control Studies; Chromatography, High Pressure Liquid; Humans; Inosine; Intraocular Pressure; Ocular Hypertension; Osmolar Concentration | 2003 |
Effects of 2-alkynyladenosine derivatives on intraocular pressure in rabbits.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Administration, Topical; Alkynes; Animals; Antihypertensive Agents; Chymotrypsin; Intraocular Pressure; Male; Ocular Hypertension; Rabbits; Time Factors | 2004 |
Involvement of adenosine A2a receptor in intraocular pressure decrease induced by 2-(1-octyn-1-yl)adenosine or 2-(6-cyano-1-hexyn-1-yl)adenosine.
Topics: Adenosine; Alkynes; Animals; Aqueous Humor; Cyclic AMP; Glaucoma; Humans; Intraocular Pressure; Kinetics; Male; Rabbits; Receptor, Adenosine A2A | 2005 |
2-(1-Hexyn-1-yl)adenosine-induced intraocular hypertension is mediated via K+ channel opening through adenosine A2A receptor in rabbits.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Alkynes; Animals; Antihypertensive Agents; Caffeine; Decanoic Acids; Glyburide; Hydroxy Acids; Hypotonic Solutions; Intraocular Pressure; Male; Ocular Hypertension; Phenethylamines; Pinacidil; Potassium Channel Blockers; Potassium Channels; Rabbits; Receptor, Adenosine A2A; Sodium Chloride; Time Factors; Xanthines | 2005 |
The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure.
Topics: Adenosine; Adenosine A3 Receptor Antagonists; Administration, Topical; Animals; Aqueous Humor; Cell Size; Cells, Cultured; Ciliary Body; Dihydropyridines; Epithelial Cells; Female; Humans; Intraocular Pressure; Male; Mice; Receptor, Adenosine A3 | 2005 |
Adenosine A2A receptor mediated protective effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on retinal ischaemia/reperfusion damage in rats.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Administration, Topical; Animals; Antihypertensive Agents; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Intraocular Pressure; Ischemic Preconditioning; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Retinal Vessels | 2006 |
Effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on ocular blood flow in rabbits.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Eye; Flavins; Intraocular Pressure; Male; Rabbits; Regional Blood Flow; Retinal Vessels; Vasodilator Agents; Xanthines | 2007 |
Barrier qualities of the mouse eye to topically applied drugs.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Administration, Topical; Animals; Carbachol; Cornea; Dihydropyridines; Eye; Female; Intraocular Pressure; Male; Mice; Miotics; Pupil; Sclera; Tonometry, Ocular; Vasodilator Agents | 2007 |
Adenosine receptor activation modulates intraocular pressure in rabbits.
Topics: Adenosine; Animals; Cyclic AMP; Intraocular Pressure; Norepinephrine; Phenylisopropyladenosine; Purinergic P1 Receptor Agonists; Rabbits; Receptors, Purinergic P1 | 1995 |
Modulation of intraocular pressure by adenosine agonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cyclic AMP; Dose-Response Relationship, Drug; Intraocular Pressure; Ocular Hypotension; Ophthalmic Solutions; Rabbits; Receptors, Purinergic P1; Vasodilator Agents | 1994 |
Characterization of ocular hypertension induced by adenosine agonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Administration, Topical; Animals; Aqueous Humor; Cats; Cornea; Eye Proteins; Intraocular Pressure; Ocular Hypertension; Phenethylamines; Phenylisopropyladenosine; Purinergic P1 Receptor Antagonists; Rabbits; Tonometry, Ocular; Vasodilator Agents | 1996 |
Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys.
Topics: Adenosine; Administration, Topical; Animals; Aqueous Humor; Drug Administration Schedule; Intraocular Pressure; Macaca fascicularis; Phenylisopropyladenosine; Theobromine | 1997 |
Effects of drugs acting on adrenergic and adenosine receptors on the intraocular pressure and the activity of adenylyl cyclase in ciliary processes and their sensitivity to pertussis toxin.
Topics: Adenosine; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenergic Agonists; Adrenergic alpha-Antagonists; Animals; Ciliary Body; Clonidine; Epinephrine; Fenoterol; Intraocular Pressure; Pertussis Toxin; Purinergic P1 Receptor Agonists; Rabbits; Receptors, Adrenergic; Receptors, Purinergic P1; Virulence Factors, Bordetella; Yohimbine | 1997 |
Contributions of adenosine receptor activation to the ocular actions of epinephrine.
Topics: Adenosine; Adrenergic Agonists; Animals; Aqueous Humor; Epinephrine; Inosine; Intraocular Pressure; Ophthalmic Solutions; Pupil; Purinergic P1 Receptor Antagonists; Rabbits; Receptors, Purinergic P1; Theobromine; Theophylline | 1999 |
Ocular effects associated with the chronic administration of the adenosine A(1) agonist cyclohexyladenosine.
Topics: Adenosine; Animals; Aqueous Humor; Drug Tolerance; Intraocular Pressure; Pupil; Purinergic P1 Receptor Agonists; Rabbits; Regression Analysis | 2000 |
Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: evidence for a dual mechanism of action.
Topics: Adenosine; Administration, Topical; Animals; Anterior Chamber; Aqueous Humor; Dose-Response Relationship, Drug; Fluorophotometry; Intraocular Pressure; Ocular Hypotension; Purinergic P1 Receptor Agonists; Rabbits | 2001 |
A(1)-, A(2A)- and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse.
Topics: Adenosine; Animals; Dihydropyridines; Dose-Response Relationship, Drug; Female; Intraocular Pressure; Male; Mice; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Time Factors | 2001 |
Deliberate arterial hypotension does not reduce intraocular pressure in pigs.
Topics: Adenosine; Animals; Hemodynamics; Hypotension, Controlled; Intracranial Pressure; Intraocular Pressure; Isoflurane; Nitroprusside; Pulmonary Gas Exchange; Swine | 1992 |
Effects of a cyclic AMP phosphodiesterase inhibitor, 8'-pivaloyloxymethyl ester of griseolic acid, on aqueous humor dynamics in rabbits.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Adenosine; Administration, Topical; Animals; Aqueous Humor; Biological Transport, Active; Blood; Eye Proteins; Fluorophotometry; Intraocular Pressure; Male; Rabbits; Tonometry, Ocular | 1991 |
A cyclic AMP phosphodiesterase inhibitor, 8'-pivaloyloxymethyl ester (POM-ester) of griseolic acid, lowers rabbit intraocular pressure.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Animals; Ciliary Body; Cornea; Cyclic GMP; Intraocular Pressure; Iris; Male; Permeability; Rabbits; Vitreous Body | 1991 |
Griseolic acid, a cAMP phosphodiesterase inhibitor, and its ester: increase in cellular cAMP levels and reduction of intraocular pressure.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Animals; Cattle; Cell Line; Cyclic AMP; Esters; Fibroblasts; Intraocular Pressure; Mice; Molecular Structure; Rabbits; Structure-Activity Relationship | 1990 |
[Changes in ocular hypotensive effect of griseolic acid with isoproterenol, timolol and melanin].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Animals; Depression, Chemical; Drug Synergism; Female; Intraocular Pressure; Isoproterenol; Male; Melanins; Rabbits; Timolol | 1990 |